Mechanism of Action and Clinical Rationale for Immunotherapy in Bladder Cancer

In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the mechanism of action and clinical rationale for the use of immune checkpoint inhibitors in patients with bladder cancer.
Format: Microsoft PowerPoint (.ppt)
File size: 3.89 MB
Date posted: 2/12/2018